+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "POC Clinical Chemistry"

In Vitro Diagnostics Business Outlook, 2024 (6 updates) - Product Thumbnail Image

In Vitro Diagnostics Business Outlook, 2024 (6 updates)

  • Report
  • January 2024
  • 35 Pages
  • Global
From
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 - Product Thumbnail Image

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

  • Report
  • October 2022
  • 348 Pages
  • Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

The POC Clinical Chemistry market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of point-of-care (POC) testing devices and reagents used to measure a variety of analytes in a clinical setting. These devices are typically small, portable, and easy to use, allowing for rapid results in a variety of settings. The POC Clinical Chemistry market is driven by the need for rapid, accurate, and cost-effective testing, as well as the increasing demand for personalized medicine. The POC Clinical Chemistry market is highly competitive, with a variety of companies offering a range of products. Some of these companies include Abbott, Roche, Siemens, Ortho Clinical Diagnostics, Sysmex, and Alere. Show Less Read more